Journey Medical Corporation
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-11.4M | $-14.7M | $-3.9M | $-29.6M | $-44.0M | $5.3M |
| Depreciation & Amortization | — | — | — | — | $0 | $5.0K |
| Depreciation | — | — | — | — | — | — |
| Amortization | $4.3M | $3.4M | $3.8M | $4.3M | $2.5M | $1.4M |
| Stock-Based Compensation | $6.3M | $6.1M | $2.6M | $4.4M | $2.5M | $153.0K |
| Net Cash from Operating Activities | $-12.4M | $-9.1M | $5.2M | $-13.5M | $-2.2M | $5.1M |
| Investing Activities | ||||||
| Capital Expenditures | — | $15.0M | $5.0M | $20.0M | — | — |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-15.0M | $-5.0M | $-20.0M | $-10.0M | $-1.2M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $16.2M | $17.0M | $-4.8M | $16.5M | $53.0M | $-487.0K |
| Net Change in Cash | $3.8M | $-7.1M | $-4.6M | $-17.1M | $40.8M | $3.4M |
| Free Cash Flow | — | $-24.1M | $240.0K | $-33.5M | — | — |